Literature DB >> 9973672

Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998.

G Saggese1, M B Ranke, P Saenger, R G Rosenfeld, T Tanaka, J L Chaussain, M O Savage.   

Abstract

This article summarizes the content of an international workshop on the diagnosis and treatment of growth hormone deficiency (GHD) in children and adolescents that was held in Pisa, Italy, in March 1998. The issues discussed are divided into those addressing the definition and diagnosis, and the treatment of GHD in children and adolescents, and those concerning the transition of patients with GHD from adolescence to adulthood. Recommendations are presented for improving the diagnosis and management of children and adolescents with GHD and issues are highlighted that require further studies to be undertaken before recommendations can be made.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9973672     DOI： 10.1159/000023298

Source DB:  PubMed          Journal:  Horm Res        ISSN： 0301-0163


  20 in total

1.  Which children should receive growth hormone treatment. Cost-benefit analysis is the key.

Authors:  C J Kelnar
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

2.  More guidance on growth hormone deficiency.

Authors:  R Ayling
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

Review 3.  Growth hormone therapy.

Authors:  Anurag Bajpai; P Sn Menon
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

Review 4.  Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED).

Authors:  G Federico; M E Street; M Maghnie; M Caruso-Nicoletti; S Loche; S Bertelloni; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

5.  Safety of the insulin tolerance test.

Authors:  P J Galloway; E McNeill; W F Paterson; M D C Donaldson
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

Review 6.  Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone mass.

Authors:  G Saggese; G I Baroncelli; T Vanacore; L Fiore; S Ruggieri; G Federico
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 7.  The use of somatropin (recombinant growth hormone) in children of short stature.

Authors:  Ameeta Mehta; Peter C Hindmarsh
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  Short stature in children: Pattern and frequency in a pediatric clinic, Riyadh, Saudi Arabia.

Authors:  Nasir A Al-Jurayyan N; Sarar H Mohamed; Hessah M Al Otaibi; Sharifah T Al Issa; Hala G Omer
Journal:  Sudan J Paediatr       Date:  2012

9.  Partial rescue of growth failure in growth hormone (GH)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the GH gene driven by a muscle-specific regulatory cassette.

Authors:  Marco Martari; Alessia Sagazio; Ali Mohamadi; Quynh Nguyen; Stephen D Hauschka; Eun Kim; Roberto Salvatori
Journal:  Hum Gene Ther       Date:  2009-07       Impact factor: 5.695

10.  Meta-analysis of metabolic changes in children with idiopathic growth hormone deficiency after recombinant human growth hormone replacement therapy.

Authors:  Yuan Yuan; Bo Zhou; Shufang Liu; Yunfeng Wang; Kundi Wang; Zhixin Zhang; Wenquan Niu
Journal:  Endocrine       Date:  2020-08-01       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.